Bashan Dror 4
4 · Protalix BioTherapeutics, Inc. · Filed Oct 20, 2023
Insider Transaction Report
Form 4
Bashan Dror
DirectorPRESIDENT AND CEO
Transactions
- Purchase
Common Stock
2023-10-19$1.40/sh+48,387$67,742→ 116,387 total - Purchase
Common Stock
2023-10-19$1.41/sh+16,129$22,742→ 132,516 total